Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.87 |
| ▸ | CHAT | P28329 | 2/20 | 0.82 |
| ▸ | EP300 | Q09472 | 3/20 | 0.80 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.80 |
| ▸ | AURKA | O14965 | 1/20 | 0.80 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.80 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL30464957 | 1.00 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL28130999 | 0.98 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL22361767 | 0.98 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL4367366 | 0.98 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29425568 | 0.98 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL60439 | 0.98 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL4358381 | 0.98 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| Methane SCHEMBL28198292 | 0.98 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Phosphoric Acid SCHEMBL30705430 | 0.98 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Methane SCHEMBL18038085 | 0.98 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250327097-A1 | ORGANISMS PRODUCING LESS CROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2025-10-23 | — | — | US | claimed |
| WO-2026043908-A1 | COMPOSITIONS AND METHODS TO IMPROVE SEQUESTRATION OF MYCOTOXINS AND THEIR USE IN DETOXIFICATION OF ANIMAL FEED AND ANIMAL PRODUCTION SYSTEMS | ALLTECH, INC. (US) | 2026-02-26 | — | — | WO | disclosed |
| EP-4288559-B1 | METHOD AND SYSTEM FOR DESIGNING PERSONALIZED THERAPEUTICS AND DIET BASED ON FUNCTIONS OF MICROBIOME | TATA CONSULTANCY SERVICES LTD (IN) | 2025-11-26 | — | — | EP | disclosed |
| US-20240127925-A1 | METHOD AND SYSTEM FOR DESIGNING PERSONALIZED THERAPEUTICS AND DIET BASED ON FUNCTIONS OF MICROBIOME | TATA CONSULTANCY SERVICES LIMITED (IN) | 2024-04-18 | — | — | US | disclosed |
| EP-2989113-B1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | GENOMATICA INC (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4288559-A1 | METHOD AND SYSTEM FOR DESIGNING PERSONALIZED THERAPEUTICS AND DIET BASED ON FUNCTIONS OF MICROBIOME | Tata Consultancy Services Limited (IN) | 2023-12-13 | — | — | EP | disclosed |
| CN-116322371-A | Human milk oligosaccharide compositions for use with bacterial therapies | 普罗莱克塔生物科学公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-115252650-A | Therapeutic microbiota for the treatment and/or prevention of food allergy | 布里格姆及妇女医院股份有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-114525214-B | Construction method and application of engineering probiotics | 天津大学 | 2022-10-14 | — | — | CN | disclosed |
| WO-2022168120-A1 | METHOD AND SYSTEM FOR DESIGNING PERSONALIZED THERAPEUTICS AND DIET BASED ON FUNCTIONS OF MICROBIOME | TATA CONSULTANCY SERVICES LIMITED (IN) | 2022-08-11 | — | — | WO | disclosed |
| CN-114525214-A | Construction method and application of engineering probiotics | 天津大学 | 2022-05-24 | — | — | CN | disclosed |
| CN-108430483-B | Therapeutic microbiota for the treatment and/or prevention of food allergy | 布里格姆及妇女医院股份有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-108473967-B | Genetically modified acetogenic cells | 赢创运营有限公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-113365645-A | Therapeutic microbiota for the treatment and/or prevention of dysbiosis | 布里格姆及妇女医院股份有限公司 | 2021-09-07 | — | — | CN | disclosed |
| CN-112638421-A | Preparation for improving intestinal health | 帝斯曼知识产权资产管理有限公司 | 2021-04-09 | — | — | CN | disclosed |